AllergyTalk Disparities in Atopic Dermatitis Miniseries Episode 3: Improving Access to Treatment for AD in Minority and Underserved Populations
Price: FREE for members and non-members
This episode will describe best practices for addressing disparities in care for patients with atopic dermatitis and how to implement specific health equity strategies to improve access to atopic dermatitis care and increase patient adherence to treatment.
Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 0.25 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Commercial Support
This podcast is supported by an independent medical education grant from Pfizer..
Target Audience
Allergists and Immunologists
Learning Objectives
Understand how to address disparities in care for patients with atopic dermatitis and how to implement specific health equity strategies to improve access to atopic dermatitis care and increase patient adherence to treatment
All relevant financial relationships have been mitigated.
Andrew Alexis, MD, MPH | Grants: Leo, Novartis, Almirall, Bristol-Myers-Squibb, Amgen, Menlo, Galderma, Valeant (Bausch Health), Cara, Arcutis, Dermavant | Advisory Board: Leo, Galderma, Pfizer, Sanofi-Regeneron, Dermavant, Beiersdof, Valeant, L'Oreal, BMS, Bausch Health, UCB, Vyne, Arcutis, Janssen, Allergan, Almirall, Abbvie, Sol-Gel, Amgen, VisualDx, Eli Lilly, Swiss American | Speaker: Regeneron, SANOFI-Genzyme, Pfizer, BMS | Royalties: Springer, Wiley-Blackwell, Wolters Kluwer Health
Payel Gupta, MD, FACAAI | Advisor, Speaker: ALK
Marcella Aquino, MD, FACAAI, FAAAAI | No financial relationships to disclose.
Anil Nanda, MD, FACAAI, FAAAAI, FACP | No financial relationships to disclose.
Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 0.25 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 0.25 AMA PRA Category 1 Credit™
- 0.25 Attendance